Accelerated diabetes in rat insulin promoter-tumor necrosis factor-α transgenic nonobese diabetic mice lacking major histocompatibility class II molecules

Diabetes

Volumn 52, Issue 2, 2003, Pages 342-347

  Rajagopalan, Govindarajan ^a   Kudva, Yogish C ^b   Flavell, Richard A ^c   David, Chella S ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETIC PREDISPOSITION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; RAT; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INCIDENCE; INSULIN; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, TRANSGENIC; PANCREAS; RATS; SEX CHARACTERISTICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037315192     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.2.342     Document Type: Article

References (39)

1. Tisch R, McDevitt H: Insulin-dependent diabetes mellitus. Cell 85:291-297, 1996
2. Field LL: Genetic linkage and association studies of type I diabetes: challenges and rewards. Diabetologia 45:21-35, 2002
3. Rosmalen JG, van Ewijk W, Leenen PJ: T-cell education in autoimmune diabetes: teachers and students. Trends Immunol 23:40-46, 2002
4. Wong FS, Janeway CA Jr: The role of CD4 vs. CD8 T cells in IDDM. J Autoimmun 13:290-295, 1999
5. Taneja V, David CS: HLA class II transgenic mice as models of human diseases. Immunol Rev 169:67-79, 1999
6. Cheta D: Animal models of type I (insulin-dependent) diabetes mellitus. J Pediatr Endocrinol Metab 11:11-19, 1998
7. Lee KH, Wucherpfennig KW, Wiley DC: Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol 2:501-507, 2001
8. Wen L, Wong FS, Sherwin R, Mora C: Human DQ8 can substitute for murine I-A(g7) in the selection of diabetogenic T cells restricted to I-A(g71). J Immunol 168:3635-3640, 2002
9. Abraham RS, Kudva YC, Wilson SB, Strominger JL, David CS: Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice. Diabetes 49:548-554, 2000
10. Abraham RS, Wen L, Marietta EV, David CS: Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cells in a transgenic model. J Immunol 166:1370-1379, 2001
11. Wen L, Wong FS, Tang J, Chen NY, Altieri M, David C, Flavell R, Sherwin R: In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J Exp Med 191:97-104, 2000
12. Wen L, Chen NY, Tang J, Sherwin R, Wong FS: The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J Clin Invest 107:871-880, 2001
13. Kudva YC, Rajagopalan G, Raju R, Abraham RS, Smart M, Hansen J, David CS: Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II. Hum Immunol 63:987-999, 2002
14. Raju R, Munn SR, Majoribanks C, David CS: Islet cell autoimmunity in NOD mice transgenic for HLA-DQ8 and lacking I-Ag7. Transplant Proc 30:561, 1998
15. Picarella DE, Kratz A, Li CB, Ruddle NH, Flavell RA: Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes: distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J Immunol 150:4136-4150, 1993
16. Green EA, Wong FS, Eshima K, Mora C, Flavell RA: Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8(+) T cells. J Exp Med 191:225-238, 2000
17. Green EA, Flavell RA: Tumor necrosis factor-alpha and the progression of diabetes in non-obese diabetic mice. Immunol Rev 169:11-22, 1999
18. Wicker LS, Todd JA, Peterson LB: Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13:179-200, 1995
19. Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoist C, Mathis D: Mice lacking MHC class II molecules. Cell 66:1051-1066, 1991
20. Mathis DJ, Benoist C, Williams VE 2nd, Kanter M, McDevitt HO: Several mechanisms can account for defective E alpha gene expression in different mouse haplotypes. Proc Natl Acad Sci U S A 80:273-277, 1983
21. Higuchi Y, Herrera P, Muniesa P, Huarte J, Belin D, Ohashi P, Aichele P, Orci L, Vassalli JD, Vassalli P: Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes. J Exp Med 176:1719-1731, 1992
22. Mora C, Wong FS, Chang CH, Flavell RA: Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice. J Immunol 162:4576-4588, 1999
23. Williams GS, Malin M, Vremec D, Chang CH, Boyd R, Benoist C, Mathis D: Mice lacking the transcription factor CIITA: a second look. Int Immunol 10:1957-1967, 1998
24. Shevach EM, McHugh RS, Piccirillo CA, Thornton AM: Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev 182:58-67, 2001
25. Bensinger SJ, Bandeira A, Jordan MS, Caton AJ, Laufer TM: Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J Exp Med 194:427-438, 2001
26. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, Sharpe A, Bluestone JA: B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431-440, 2000
27. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, Sanz M, Exley M, Wilson B, Porcelli S, Maclaren N: Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 109:131-140, 2002
28. Green EA, Choi Y, Flavell RA: Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 16:183-191, 2002
29. McHugh RS, Shevach EM: Depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 168:5979-5983, 2002
30. Tarbell KV, Lee M, Ranheim E, Chao CC, Sanna M, Kim SK, Dickie P, Teyton L, Davis M, McDevitt H: CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer. J Exp Med 196:481-492, 2002
31. Graca L, Thompson S, Lin CY, Adams E, Cobbold SP, Waldmann H: Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J Immunol 168:5558-5565, 2002
32. Wolf M, Schimpl A, Hunig T: Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms. Eur J Immunol 31:1637-1645, 2001
33. Anderson B, Park BJ, Verdaguer J, Amrani A, Santamaria P: Prevalent CD8(+) T cell response against one peptide/MHC complex in autoimmune diabetes. Proc Natl Acad Sci U S A 96:9311-9316, 1999
34. Wong FS, Visintin I, Wen L, Flavell RA, Janeway CA Jr: CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 183:67-76, 1996
35. Quinn A, McInerney MF, Sercarz EE: MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity. J Immunol 167:1748-1757, 2001
36. Green EA, Eynon EE, Flavell RA: Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 9:733-743, 1998
37. Pakala SV, Chivetta M, Kelly CB, Katz JD: In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J Exp Med 189:1053-1062, 1999
38. Mathis D, Vence L, Benoist C: Beta-cell death during progression to diabetes. Nature 414:792-798, 2001
39. Zhang Y, O'Brien B, Trudeau J, Tan R, Santamaria P, Dutz JP: In situ beta cell death promotes priming of diabetogenic CD8 T lymphocytes. J Immunol 168:1466-1472, 2002